Literature DB >> 8010458

The role of continuous background infusions in patient-controlled epidural analgesia for labor and delivery.

F M Ferrante1, F A Rosinia, C Gordon, S Datta.   

Abstract

The use of a background infusion with intravenous patient-controlled analgesia (IV-PCA) increases drug consumption without any additional contribution to analgesia. There are no data on the potential advantage of a background infusion administered with patient-controlled epidural analgesia (PCEA) for labor and delivery. Sixty women were randomized to one of four groups and received either: (a) demand dose PCEA (demand dose = 3 mL; lockout interval = 10 min); (b) continuous infusion plus demand dose PCEA (two separate infusion rates: 3 mL/h and 6 mL/h); or (c) a fixed-rate continuous epidural infusion (CEI) at 12 mL/h. All patients received 0.125% bupivacaine with 2 micrograms/mL of fentanyl. The study protocol was double-blind and placebo-controlled. Visual analog pain scores, motor strength, and bilateral pinprick analgesia were assessed every half hour by a blinded observer. Pain scores, cephalad extent of sensory analgesia, and motor block were no different among the study groups during the first and second stages of labor. Cumulative hourly bupivacaine use was similar among all PCEA study groups. However, use of PCEA (in whatever mode) provided a 35% dose-sparing effect in comparison to CEI. The PCEA groups receiving no background infusion or a 3-mL/h background infusion had a greater need for physician-administered supplemental bupivacaine during the first stage of labor. While not statistically significant, a trend toward increased need for supplementation was seen in these same patient groups over the entire course of labor and delivery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8010458     DOI: 10.1213/00000539-199407000-00015

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Recent developments in analgesia during labour.

Authors:  R E Kan; S C Hughes
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

2.  Patient-controlled epidural analgesia during labor using ropivacaine and fentanyl provides better maternal satisfaction with less local anesthetic requirement.

Authors:  Miwako Saito; Toshiyuki Okutomi; Yuji Kanai; Junko Mochizuki; Akihiro Tani; Kan Amano; Sumio Hoka
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

3.  Current status of obstetric anaesthesia: improving satisfaction and safety.

Authors:  J Sudharma Ranasinghe; David Birnbach
Journal:  Indian J Anaesth       Date:  2009-10

4.  Progress in analgesia for labor: focus on neuraxial blocks.

Authors:  J Sudharma Ranasinghe; David J Birnbach
Journal:  Int J Womens Health       Date:  2010-08-09

5.  Patient Controlled Epidural Analgesia during Labour: Effect of Addition of Background Infusion on Quality of Analgesia & Maternal Satisfaction.

Authors:  Uma Srivastava; Amrita Gupta; Surekha Saxena; Aditya Kumar; Saroj Singh; Namita Saraswat; Abhijeet R Mishra; Ashish Kannaujia; Sukhdev Mishra
Journal:  Indian J Anaesth       Date:  2009-12

6.  Comparison of computer-integrated patient-controlled epidural analgesia with no initial basal infusion versus moderate basal infusion for labor and delivery: A randomized controlled trial.

Authors:  Ban Leong Sng; David Woo; Wan Ling Leong; Hao Wang; Pryseley Nkouibert Assam; Alex Th Sia
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-10

7.  Parturient Controlled Epidural Analgesia with and without Basal Infusion of Ropivacaine and Fentanyl: A Randomized Trial.

Authors:  Garima Choudhary; Kriti Chaudhary; Ravi Shankar Sharma; Shobha Ujwal; Jagdish Kumawat; Rashmi Syal
Journal:  Anesth Essays Res       Date:  2021-03-22

8.  Comparison of Continuous Epidural Infusion of Bupivacaine and Fentanyl Versus Patient Controlled Analgesia Techniques for Labor Analgesia: A Randomized Controlled Trial (RCT).

Authors:  Raha Khaneshi; Sousan Rasooli; Farnaz Moslemi; Sanam Fakour
Journal:  J Reprod Infertil       Date:  2020 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.